Phesi
Business Services · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
PO Box 82, East Lyme, Connecticut, 06333...Phone Number
(860) 739-8666Website
www.phesi.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Phesi
Phesi provides comprehensive clinical development analytical products and services for biopharmaceutical companies around the world. The company's integrated offerings cover the entire clinical development process - from development planning and indication assessment to protocol evaluation, site selection, and trial implementation management. Phesi has the industry's most comprehensive and dynamic clinical trials database and predictive analytics tools, consisting of 330,000 completed clinical trials, 604,000 completed research projects, 4.2 million physicians, and 1.8 million investigator records. ClinSite, a Software as a Service (SaaS) solution that incorporates natural language processing and machine learning, is an evolution of the technology Phesi patented in 2007 and fully automated in 2018.Explore more
Phesi Org Chart
GW
Chief Information Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Phesi your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Phesi
Check if Phesi has recently received funding, and reach out quickly before it becomes old news!
Check out if Phesi is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Phesi had a recent Job posting/layoffs
Product Launch: Get notified when Phesi launches new products
Funding: Get notified immidiatlly once Phesi has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Phesi recently announced quarterly report
Phesi, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Phesi
Compare insights from companies similar to Phesi, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Phesi is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Phesi is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Phesi.
Phesi Tech Stack
A closer look at the technologies used by Phesi
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Event
Product Marketing, Events, Training, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Technology
Event
Product Marketing, Events, Software, Field /Outside Sales, Field Marketing, Healthcare Operations, Healthcare Technology
Phesi News & Media
Sensyne grows medical research dataset to 60 million patients
OXFORD, England--(BUSINESS WIRE)--Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the ethical Clinical AI company, today announces that it has reached a milestone of access to a combined clinical research, clinical trial and real world de-identified and anonymized dataset of over 60 million patients. This enlarged dataset results from both Sensyne’s investment in virtual clinical development company, Phesi Inc. in January 2021, and the progress made by Sensyne and PhSensyne Health and Phesi Enter Joint Commercial Development Collaboration with a Leading Pharmaceutical Company
OXFORD, England & DOVER, Del.--(BUSINESS WIRE)--Sensyne and Phesi Enter Joint Commercial Development Collaboration with a Leading Pharmaceutical CompanyNew Patent Filing Completes Phesi’s Integrated Clinical Trial Design and Protocol Optimization Platform
EAST LYME, Conn.--(BUSINESS WIRE)-- #Phesi--New patent filing completes Phesi’s integrated clinical trial design and protocol optimization platformOncoSec Secures Phesi ClinSite™ License to Select Clinical Trial Investigator Sites
EAST LYME, Conn.--(BUSINESS WIRE)-- #Phesi--OncoSec secures Phesi ClinSite license to select clinical trial investigator sites for Phase 2 & 3 clinical trials of anticancer immunotherapies
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Phesi
Sign Up For FreeTo access detailed company insights
Phesi provides comprehensive clinical development analytical products and services for biopharmaceutical companies around the world. The company's integrated offerings cover the entire clinical development process - from development planning and indication assessment to protocol evaluation, site selection, and trial implementation management. Phesi... Read More
